GSK Scores Midtrial Dismissal Of Paxil Birth Defect Suit
GlaxoSmithKline PLC on Monday scored a midtrial dismissal of claims that its antidepressant Paxil caused cardiac birth defects as a Pennsylvania state judge ruled that the plaintiffs hadn't presented sufficient evidence...To view the full article, register now.
Already a subscriber? Click here to view full article